topSkip to main content

Menu, Secondary

Menu Trigger



Researchers have developed an online tool that helps people who care for those with dementia by helping them anticipate and respond to the behavioral and psychological symptoms of the illness.
Through a $206,184 grant over three years from the Alzheimer’s Foundation of America (AFA), Stony Brook University and Stony Brook Medicine will undertake an innovative Positron Emission Tomography (PET) imaging research project that will bring new insights into the origins of Alzheimer’s disease.
University at Buffalo biologist Shermali Gunawardena is looking for deeper explanations into the causes of Alzheimer’s and how this debilitating condition can be treated.
Education gives people an edge in their later years, helping them to keep dementia at bay and their memories intact, a new USC-led study has found.
Researchers have developed an online tool that helps older people monitor their brain health and addresses a major obstacle to finding early Alzheimer’s treatments: significant delays in clinical trial enrollment.
A Canadian study shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer’s, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.
An alteration in Andrés Martín’s DNA called the Jalisco mutation dramatically raises his risk for early-onset Alzheimer’s. He found a powerful ally in USC neurologist and Alzheimer’s researcher John Ringman.
USC research sheds new light on how a breakdown in the brain’s vascular system predates the accumulation of toxic plaques and tangles in the brain that bring about Alzheimer’s disease. The research suggests an earlier target for preventing dementia and Alzheimer’s.
An enzyme found in brain cells can break apart the precursors to plaques that accumulate in the organ and cause toxicity in Alzheimer’s disease, according to a new study led by Weill Cornell Medicine scientists.
University of Florida neuroscientists have validated a potential pathway to halt the progression of Alzheimer’s disease.